Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Q: What does CUSIP 87184Q206 represent in this 13F holders report?

CUSIP 87184Q206 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share in Q2 2023?

52 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 87184Q206

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 27,196,692
Total 13F shares: 10,623,066
Share change: +320,978
Total reported value: $33,463,045
Price per share: $3.15
Number of holders: 52
Value change: +$1,179,405
Number of buys: 15
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 87184Q206?
CUSIP 87184Q206 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 87184Q206:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bain Capital Life Sciences Investors, LLC	13F	Company	7.8%	2,124,694	$5,673,000	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	5.4%	1,475,744	$3,940,000	—	31 Mar 2023	13F
Flagship Pioneering, LLC	13F	Company	3.7%	993,848	$2,653,574	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	3.3%	904,630	$2,415,362	—	31 Mar 2023	13F
Samsara BioCapital, LLC	13F	Company	3.2%	881,450	$2,353,472	—	31 Mar 2023	13F
CHI Advisors LLC	13F	Company	2.8%	767,445	$2,049,078	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.7%	721,914	$1,927,510	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.8%	487,222	$1,300,883	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.98%	265,878	$709,894	—	31 Mar 2023	13F
Omega Fund Management, LLC	13F	Company	0.92%	251,270	$670,891	—	31 Mar 2023	13F
Ally Bridge Group (NY) LLC	13F	Company	0.92%	249,126	$665,166	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.69%	188,154	$502,372	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.45%	121,555	$325,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.39%	105,232	$280,969	—	31 Mar 2023	13F
LPL Financial LLC	13F	Company	0.31%	83,189	$222,115	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.31%	83,079	$221,820	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.29%	78,336	$209,000	—	31 Mar 2023	13F
LGT CAPITAL PARTNERS LTD.	13F	Company	0.2%	55,000	$146,850	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	49,500	$132,165	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.17%	45,835	$122,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.12%	33,130	$88,457	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.11%	30,551	$81,572	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.11%	30,226	$80,703	—	31 Mar 2023	13F
Corient Private Wealth LLC	13F	Company	0.1%	26,666	$71,198	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.08%	22,550	$61,000	—	31 Mar 2023	13F
1492 Capital Management LLC	13F	Company	0.08%	21,744	$58,057	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.08%	20,727	$55,341	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	19,633	$52,420	—	31 Mar 2023	13F
Clarius Group, LLC	13F	Company	0.07%	18,620	$49,715	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.06%	16,847	$45,000	—	31 Mar 2023	13F
CIBC Asset Management Inc	13F	Company	0.06%	15,398	$41,113	—	31 Mar 2023	13F
HighTower Advisors, LLC	13F	Company	0.06%	15,004	$40,000	—	31 Mar 2023	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	14,899	$39,780	—	31 Mar 2023	13F
Shay Capital LLC	13F	Company	0.05%	14,109	$37,671	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	13,600	$36,312	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.05%	12,991	$34,686	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.05%	12,776	$34,000	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.04%	10,376	$27,704	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	6,584	$18,000	—	31 Mar 2023	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	0.02%	4,382	$11,700	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0%	1,279	$3,415	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,115	$2,977	—	31 Mar 2023	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0%	1,095	$2,924	—	31 Mar 2023	13F
IFP Advisors, Inc	13F	Company	0%	438	$2,663	—	31 Mar 2023	13F
Russell Investments Group, Ltd.	13F	Company	0%	750	$2,002	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	596	$2,000	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	746	$1,992	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0%	252	$1,000	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	223	$594	—	31 Mar 2023	13F
Ten Capital Wealth Advisors, LLC	13F	Company	0%	219	$585	—	31 Mar 2023	13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) as of Q2 2023

As of 30 Jun 2023, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,623,066 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, Artal Group S.A., Avidity Partners Management LP, Flagship Pioneering Inc., Samsara BioCapital, LLC, CHI Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, DAFNA Capital Management LLC, and Omega Fund Management, LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

-1

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.